Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Trifarotene is a retinoic acid receptor γ (RARγ) agonist.1 It is selective for RARγ over RARα and RARβ in reporter assays using HeLa cells expressing chimeric RARγ, RARα, or RARβ receptors (EC50s = 7.7, 498, and 125 nM, respectively) and is inactive at the retinoid X receptor (RXR). Topical application of trifarotene (0.1% w/w) reduces ear edema induced by 12-O-tetradecanoylphorbol-1,3-acetate (TPA; Item No. 10008014) in a mouse model of epidermal inflammation. Formulations containing trifarotene have been used in the treatment of acne vulgaris.
WARNING This product is not for human or veterinary use.
1. Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-